Today's Reuters Health News Headlines - Yahoo! News:
|
|
Haitian president condemns storming of Parliament
Wed,18 Apr 2012 05:56 PM PDT
Reuters -  PORT-AU-PRINCE (Reuters) - Haitian President Michel Martelly, who was recovering in a Miami hospital on Wednesday from a blood clot in his lung, condemned the gunmen who stormed and briefly occupied the lower chamber of Parliament in Haiti's capital a day earlier. No shots were fired and no injuries reported during the tense incident that cut short the Chamber of Deputies' session on Tuesday. The intruders left the chamber without firing any shots. ...
Full Story | Top |
Farm group seeks U.S. halt on "dangerous" crop chemicals
Wed,18 Apr 2012 03:23 PM PDT
Reuters -  (Reuters) - A coalition of more than 2,000 U.S. farmers and food companies said Wednesday it is taking legal action to force government regulators to analyze potential problems with proposed biotech crops and the weed-killing chemicals to be sprayed over them. Dow AgroSciences, a unit of Dow Chemical, and Monsanto Co. are among several global chemical and seed companies racing to roll out combinations of genetically altered crops and new herbicides designed to work with the crops as a way to counter rapidly spreading herbicide-resistant weeds that are choking millions of acres of U.S. ...
Full Story | Top |
Watergate figure, ministry founder Colson near death
Wed,18 Apr 2012 02:39 PM PDT
Reuters -  WASHINGTON (Reuters) - Chuck Colson, an aide to President Richard Nixon who went to jail over the Watergate scandal and later became an evangelical Christian and founder of a prison ministry, was near death on Wednesday at a Northern Virginia hospital, his associate said. Colson, 80, underwent surgery more than two weeks ago to remove clotting on his brain and there had been some "hopeful signs" during his recovery, Jim Liske, chief executive of Prison Fellowship Ministries, said in a message to staff on the organization's website. ...
Full Story | Top |
U.S. officials seize contaminated ultrasound gel
Wed,18 Apr 2012 01:34 PM PDT
Reuters - WASHINGTON (Reuters) - U.S. officials on Wednesday confiscated ultrasound gel in New Jersey that health regulators believe infected 16 surgical patients with a potentially deadly bacteria. The U.S. Food and Drug Administration said the gel posed "serious health risks" after finding samples of the product were contaminated with two different strains of bacteria. The gel, called Other-Sonic Generic Ultrasound Transmission Gel, is made by privately held Pharmaceutical Innovations Inc in Newark, New Jersey. ... Full Story | Top |
Top doctors aim to fix record on gums-heart link
Wed,18 Apr 2012 01:05 PM PDT
Reuters -  NEW YORK (Reuters) - For 20 years, researchers have reported a link between gum disease and heart attacks or stroke, but a new analysis finds that claim seriously flawed - so much so that the American Heart Association (AHA) issued a rare "scientific statement" on Wednesday concluding that gum disease has not been shown to raise the risk of, let alone cause, cardiovascular illness. Moreover, the statement continued, treating gum disease either professionally or by regular brushing and flossing has not been proven to reduce the risk of heart disease or stroke. ...
Full Story | Top |
Cancer patients rarely speak up about care problems
Wed,18 Apr 2012 01:00 PM PDT
Reuters -  NEW YORK (Reuters Health) - In a new survey of cancer patients, many people who'd had problems with their treatment never said anything to the doctor they thought was responsible -- and almost none formally reported the problems to the hospital. Patients cited delays in treatment, surgical complications and other issues related to medical care, in addition to communication barriers or breakdowns between them and their doctors, as the most common potentially harmful problems. ...
Full Story | Top |
Roche set to walk away from $6.8 billion Illumina bid
Wed,18 Apr 2012 11:53 AM PDT
Reuters -  ZURICH/NEW YORK (Reuters) - Swiss drugmaker Roche said on Wednesday it would not extend a $6.8 billion hostile offer for genetic specialist Illumina as the U.S. group's shareholders blocked its move to appoint new directors. Roche, which is now set to walk away from its takeover target, said an offer above $51.00 per share would not be in the interests of its own shareholders. The tender offer for Illumina expires on Friday and Roche said it would not extend the bid as the U.S. firm's management had refused to engage in constructive dialogue. ...
Full Story | Top |
SXC to buy Catalyst in $4.4 billion drug benefit deal
Wed,18 Apr 2012 11:20 AM PDT
Reuters - (Reuters) - SXC Health Solutions Corp said it will buy rival pharmacy benefit manager Catalyst Health Solutions Inc for $4.4 billion as it seeks to keep pace in the rapidly consolidating market for managing Americans' prescriptions. The deal comes only two weeks after Express Scripts Inc closed its $29 billion acquisition of Medco Health Solutions, creating the clear leader in the pharmacy benefit management (PBM) sector. ... Full Story | Top |
Acne drug tied to a doubled risk of eye problems
Wed,18 Apr 2012 11:03 AM PDT
Reuters - NEW YORK (Reuters Health) - Prescription pills used to treat severe acne were linked to a two-fold risk of developing eye problems, such as pink eye, styes and dryness, in a large new study from Israel. Isotretinoin, which goes by brand names including Roaccutane, Claravis and Amnesteem, is known to have serious side effects, such as bone growth delays in teenagers and miscarriages and birth defects when taken by pregnant women. The medications are quite popular, however, for treating severe cases of acne in both teens and adults. ... Full Story | Top |
Instant View: Warren Buffett says he has Stage 1 prostate cancer
Wed,18 Apr 2012 10:06 AM PDT
Reuters - (Reuters) - Berkshire Hathaway Inc Chief Executive Warren Buffett said he has stage 1 prostate cancer and will begin a two-month treatment in mid-July consisting of daily radiation treatments. Buffett, 81, said in a statement that his condition "is not remotely life-threatening or even debilitating in any meaningful way." Berkshire shares fell 1.5 percent in after-hours trading on the news. COMMENTARY: MICHAEL YOSHIKAMI, CEO OF DESTINATION WEALTH MANAGEMENT "My guess is that the cancer diagnosis was partially behind the depth of the succession disclosure. ... Full Story | Top |
Study suggests breast cancer is clutch of 10 diseases
Wed,18 Apr 2012 10:02 AM PDT
Reuters -  LONDON (Reuters) - Scientists who conducted a major international study into the genetics of breast cancer say they can now classify the disease into 10 subtypes - a finding that points to more accurate, tailored treatment for individual patients in future. In research published in the journal Nature on Wednesday, a team led by scientists at the Cancer Research UK (CRUK) charity also found several completely new genes that drive breast cancer, offering potential targets for new types of drugs. ...
Full Story | Top |
Value of screening for kidney disease unclear
Wed,18 Apr 2012 09:05 AM PDT
Reuters -  NEW YORK (Reuters Health) - Screening people to catch early kidney disease may sound like a good idea, but there is no research to prove that it's worthwhile, according to a new review. In the U.S., about 11 percent of adults have chronic kidney disease, the vast majority of whom have early-stage disease. The disease is very common among older adults -- more than 44 percent of Americans older than 70 have it -- and high blood pressure and diabetes are the main risk factors. In its early stages, chronic kidney disease usually has no symptoms. ...
Full Story | Top |
"Five S's" ease babies' pain during vaccinations
Wed,18 Apr 2012 08:55 AM PDT
Reuters - NEW YORK (Reuters Health) - Some physical comfort and a soothing voice may make routine vaccinations a little easier on babies without resorting to painkillers like acetaminophen, a new study suggests. It's no secret that vaccine jabs create distress, for infants and parents alike. The usual routine in pediatricians' offices is to get the shots done quickly and then pass the baby into mom's arms for some comfort. But in the new study, researchers tested the so-called "5 S's" approach -- a method of soothing a fussy baby popularized by pediatrician Dr. ... Full Story | Top |
American CEO quits Nippon Sheet after "disagreements"
Wed,18 Apr 2012 05:58 AM PDT
Reuters -  TOKYO (Reuters) - The American president and chief executive of Nippon Sheet Glass Co Ltd quit the company after less than two years in the post following "fundamental disagreements" with the board over strategy, chairman Katsuji Fujimoto said on Wednesday. The resignation of Craig Naylor leaves Carlos Ghosn, the chief executive of Nissan Motor Co , as the only remaining non-Japanese CEO of a major Japanese manufacturer. Howard Stringer stepped aside as CEO of Sony Corp this month. ...
Full Story | Top |
Spain seeks health care cuts as crisis deepens
Wed,18 Apr 2012 05:52 AM PDT
Reuters - MADRID (Reuters) - Spain's government met regional officials on Wednesday to agree ways to cut state healthcare, an attack on a treasured welfare system that will fuel anger among a population weary of EU-enforced austerity to tackle a ballooning deficit. The conservative government has warned Spaniards they would have to start paying more for prescriptions, part of the welfare system that has provided state-financed health and education since the country's transition to democracy began in the 1970s. ... Full Story | Top |
| |
|
No comments:
Post a Comment